Corporate Reporting

Fornix BioSciences focuses among other things on the development and launching of innovative medicines. It produces and sells diagnostic and therapeutic allergen products, medical tools and microbiological products and trades in patented medicines.

Being a listed company, the publication of a paper annual is mandatory. The annual report has to meet the various requirements and guidelines, and must have the appearance one may expect of a reputable company.

The Annual Report must be published according to strict deadlines - at least 14 days before the general meeting of stockholders. Fornix mandated the coordination of the annual report to Imprima Amsterdam. CEO Cees Bergmandoes was confident in the ability of Imprima to provide the best in quality and innovation. Outsourcing this task allowed Fornix the flexibility and freedom to focus on the the message of the annual report and the business. For Cees Bergman it was of great importance to know that one contact person and company was controlling the whole process.

Imprima's service encompassed the following tasks

• Design - producing the style templates
• Copy - coordinating the copywriter
• Photography
• Layout
• Printing and binding

The Fornix annual report has been nominated several times already for the Sijthoff Award - for quality and clarity of form and for its content - this highlights how the annual report is an excellent and vital product to communicate the company's vision, results and business

Imprima also delivered an online version as well as the paper version as through its iReports technology. iReports allows shareholders to retrieve an annual report via the website quickly and efficiently without any additional software. The 'paper' annual report is translated one on one into a digital version. In addition, a search option and counter enables the client to see how many times a page has been viewed.